Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae

被引:105
作者
Deeks, SL
Palacio, R
Ruvinsky, R
Kertesz, DA
Hortal, M
Rossi, A
Spika, JS
Di Fabio, JL
机构
[1] Hlth Canada, Bur Infect Dis, Lab Ctr Dis Control, Ottawa, ON 060 3E1, Canada
[2] Hlth Canada, Lab Ctr Dis Control, Field Epidemiol Training Program, Ottawa, ON K1A 0L2, Canada
[3] Cent Publ Hlth Lab, Montevideo, Uruguay
[4] Minist Salud Publ Nacion, Acute Respiratory Infect Program, Buenos Aires, DF, Argentina
[5] Inst Nacl Microbiol Dr C Malbran, Dept Bacteriol, Buenos Aires, DF, Argentina
[6] Pan Amer Hlth Org, Washington, DC USA
关键词
pneumococcal disease; penicillin resistance; penicillin susceptibility; Streptococcus pneumoniae;
D O I
10.1542/peds.103.2.409
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. To assess differences in risk factors, clinical presentation, and course of illness between factors children infected with penicillin-sensitive and drug-resistant Streptococcus pneumoniae (DRSP). Design. A retrospective cohort study conducted in Uruguay and Argentina using information from a hospital-based surveillance system. Hospitalized children 5 years of age and younger who had S pneumoniae isolated from a normally sterile site between June 1993 and October 1996 were eligible. Hospital records were linked with surveillance data. Both stratified univariate analysis and logistic regression was completed. Results. Of the 380 children eligible for the study, 274 records (72%) were available for review. Ninety-nine children (36%) had DRSP; 46 showed intermediate susceptibility (minimum inhibitory concentration, 0.12-1.0 mu g/mL) and 53 showed high-level resistance (minimum inhibitory concentration greater than or equal to 2.0 mu g/mL). Children with meningitis were less likely to have DRSP than those with other forms of invasive disease (relative risk = 0.5; 95% confidence interval [CI], 0.2-0.9). Risk factors associated with DRSP were use of penicillin or ampicillin in the 3 months before illness (odds ratio = 2.9; 95% CI, 1.5-5.7) and possession of private medical coverage (odds ratio = 2.4; 95% CI, 1.2-5.0). Response to therapy, including response to penicillin or ampicillin among children with nonmeningeal invasive disease, course of illness, and clinical outcome did not differ significantly between children infected with penicillin-susceptible or penicillin-resistant isolates. Conclusion. In this study, previous use of penicillin or ampicillin and private medical coverage were associated with having DRSP. Children with nonmeningeal invasive disease responded equally well to penicillin regardless of the penicillin susceptibility of their pneumococcal isolate.
引用
收藏
页码:409 / 413
页数:5
相关论文
共 25 条
[1]  
[Anonymous], 1996, MMWR Recomm Rep, V45, P1
[3]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[4]   Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: Findings of a French survey [J].
Bedos, JP ;
Chevret, S ;
Chastang, C ;
Geslin, P ;
Regnier, B .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (01) :63-72
[5]  
Brandileone MCD, 1997, MICROB DRUG RESIST, V3, P141
[6]   EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES [J].
BREIMAN, RF ;
BUTLER, JC ;
TENOVER, FC ;
ELLIOTT, JA ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1831-1835
[7]   The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the centers for disease control and prevention's pneumococcal sentinel surveillance system [J].
Butler, JC ;
Hofmann, J ;
Cetron, MS ;
Elliott, JA ;
Facklam, RR ;
Breiman, RF ;
Camp, C ;
Charache, P ;
Dern, R ;
Jackson, M ;
Hadley, WK ;
HoppeBauer, J ;
Jacobs, MR ;
Schreiber, J ;
Boxerbaum, B ;
Menuey, BC ;
Tyler, PG ;
Monahan, J ;
Moore, H ;
Siegel, JD ;
Sherer, D ;
Rogers, P ;
Welch, D ;
Fine, D ;
Radike, J ;
Fiore, A ;
Alexander, M ;
Deaver, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :986-993
[8]   Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children [J].
Castaneda, E ;
Leal, AL ;
Castillo, O ;
DeLaHoz, F ;
Vela, MC ;
Arango, M ;
Trujillo, H ;
Levy, A ;
Gama, ME ;
Calle, M ;
Valencia, ML ;
Parra, W ;
Agudelo, N ;
Mejia, GI ;
Jaramillo, S ;
Montoya, F ;
Porras, H ;
Sanchez, A ;
Saa, D ;
DiFAbio, JL ;
Homma, A ;
Rios, AM ;
Ovalle, MV ;
Serrato, J ;
Navarrete, MR ;
Garcia, M ;
Aristizabal, G ;
Tovar, A ;
Paredes, C ;
Arenas, A ;
Zapata, C ;
Robledo, J ;
Correa, N ;
Suarez, C ;
Garcia, V ;
Gallardo, LM ;
Moreno, A ;
Villamarin, N ;
Bohorquez, AL ;
Lopez, P ;
Guerrero, J .
MICROBIAL DRUG RESISTANCE, 1997, 3 (02) :147-152
[9]   Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study [J].
ClavoSanchez, AJ ;
GironGonzalez, JA ;
LopezPrieto, D ;
CanuetoQuintero, J ;
SanchezPorto, A ;
VergaraCampos, A ;
MarinCasanova, P ;
CordobaDona, JA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1052-1059
[10]   Pan American Health Organization Epidemiological Surveillance Network for Streptococcus pneumoniae [J].
DiFabio, JL ;
Homma, A ;
DeQuadros, C .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (02) :131-133